Drupal.behaviors.print = function(context) {window.print();window.close();}>
Despite Concerns About Research Budgets, Genomic Tools and MDx Stocks Rise In 1H 2012
July 06, 2012
Despite Concerns About Research Budgets, Genomic Tools and MDx Stocks Rise In 1H 2012
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
CombiMatrix Leads GWDN Index for December as Sequestration Fears Fail to Make a Dent
January 2, 2013 / GenomeWeb Daily News
Shares of Accelr8, CombiMatrix Jump Sharply in May
June 1, 2011 / GenomeWeb Daily News
Accelr8's 160 Percent Jump Leads Mixed Month for 'Omics, MDx Stocks
May 2, 2012 / GenomeWeb Daily News
Complete Genomics' Stock Rebounds as Genomics Firms See Mixed February
March 2, 2012 / GenomeWeb Daily News
Despite End-Market Concerns, Genomic Tools Vendors Keep up R&D Pace
September 15, 2011 / GenomeWeb Daily News